Company Update (NASDAQ:GILD): Gilead Sciences to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11

[Business Wire] – Gilead Sciences, Inc. today announced that its corporate presentation will be webcast from the 34th Annual J.P. Morgan Healthcare Conference in San Francisco. Read more on this. Gilead Sciences Inc. (GILD) , currently valued at $139.00B, started trading this morning at $96.97. A quick look at the market, the company’s stock traded between $96.41 and $97.99 with a trailing 52-week range being $86.00 to $123.37. Priced at 7.90x this year’s forecasted earnings, GILD shares are relatively expensive compared to the industry’s -6.15x forward p/e ratio. The company pays shareholders $1.72 per share in dividend income per year, for a current yield of 1.73%. According to a consensus of 18 analysts, the earnings estimate of $2.98 per share would be $0.55 better than the year-ago quarter and a $0.18 sequential increase. Investors should also note that the full-year EPS estimate of $12.19 is a $4.10 better when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $8.09 Billion. If reported, that would be a 10.67% increase over the year-ago quarter. More recently, Morgan Stanley downgraded GILD from Overweight to Equal-Weight (Oct 2, 2015). Previously, Jefferies Initiated GILD at to Hold. With the above information in mind, readers should note that the average price target is $123.44, which is 27.30% above where the stock opened this morning. See more in (NASDAQ:GILD) Similar Articles: Market Update (NASDAQ:GILD): Gilead Sciences to Present at the Credit Suisse 24th Annual Healthcare Conference on Tuesday, November 10 Market Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Sciences Announces Fourth Quarter 2015 Dividend Company Update: Gilead Sciences Inc (NASDAQ:GILD) – Gilead Sciences to Release Third Quarter 2015 Financial Results on Tuesday, October 27, 2015